Specify a stock or a cryptocurrency in the search bar to get a summary
Shandong Xinhua Pharmaceutical Company Limited
XINShandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China. Address: Chemical Industry Area, Zibo, China, 255005
Analytics
WallStreet Target Price
–P/E ratio
8.375Dividend Yield
5.46 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures XIN
Dividend Analytics XIN
Dividend growth over 5 years
106 %Continuous growth
1 yearPayout Ratio 5 years average
28 %Dividend History XIN
Stock Valuation XIN
Financials XIN
Results | 2019 | Dynamics |